CALC.NASDAQCalcimedica, INC

8-K: CalciMedica Announces Board Changes: Director Resigns, New Director Appointed

Sentiment:

8-K Filing


CalciMedica reports the resignation of Eric Bjerkholt from the board and the appointment of Alan Glicklich, M.D., as a new Class I director.

Summary

  • On January 10, 2025, Eric Bjerkholt resigned from CalciMedica's board of directors and as Chair and member of the audit committee, effective January 15, 2025.
  • The resignation was not due to any disagreement with the company.
  • On January 13, 2025, Alan Glicklich, M.D., was appointed as a Class I director, effective January 15, 2025, with a term expiring at the 2027 annual meeting.
  • Dr. Glicklich will receive an annual cash retainer of $40,000, pro-rated for his service, and an option to purchase 20,000 shares of CalciMedica's common stock, vesting monthly over three years.
  • Dr. Glicklich will also enter into the company's standard Indemnity Agreement for directors.

Sentiment

Score: 5

Explanation: The announcement is neutral, detailing standard corporate governance procedures.

Positives

  • The company swiftly appointed a new director to fill the vacancy.

Industry Context

Board changes are a normal part of corporate governance, and the appointment of a new director is a routine event.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Board Member and Chair of Audit CommitteeEric BjerkholtAlan Glicklich (as Board Member)2025-01-15Resignation and Appointment

Stakeholder Impact

  • Shareholders may be interested in the board composition and governance changes.

Key Dates

DateDescription
2020-09-04Filing date of the Companys Registration Statement on Form S-1 with the SEC.
2025-01-10Eric Bjerkholt tendered his resignation.
2025-01-13Alan Glicklich, M.D., was appointed as a Class I director.
2025-01-14Date of report.
2025-01-15Effective date of Eric Bjerkholt's resignation and Alan Glicklich's appointment.
2027Expiration of Alan Glicklich's term at the annual meeting of stockholders.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.